|
|
|
Volumn 13, Issue 6, 2010, Pages 360-362
|
|
American association for cancer research - 101st annual meeting - Investigating new therapeutic candidates: Part 2
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
1 (1 CYANO 1 METHYLETHYL) 3 METHYL 8 (3 QUINOLINYL)IMIDAZO[4,5 C]QUINOLIN 2(1H,3H) ONE;
5 (4 BROMO 2 CHLOROANILINO) 4 FLUORO 1 METHYL 1H BENZIMIDAZOLE 6 CARBOHYDROXAMIC ACID 2 HYDROXYETHYL ESTER;
ANTINEOPLASTIC AGENT;
BKM 120;
ERLOTINIB;
PF 05177624;
PF 05197281;
PF 4691502;
RO 5323441;
SORAFENIB;
TRASTUZUMAB;
UNCLASSIFIED DRUG;
VB 111;
ANTINEOPLASTIC ACTIVITY;
APOPTOSIS;
BREAST CANCER;
CANCER RESEARCH;
CELL PROLIFERATION;
CLINICAL TRIAL;
CONFERENCE PAPER;
DOSE RESPONSE;
DRUG DOSE ESCALATION;
DRUG EFFECT;
DRUG INHIBITION;
HUMAN;
KIDNEY CARCINOMA;
LIVER CELL CARCINOMA;
LUNG NON SMALL CELL CANCER;
NONHUMAN;
SOLID TUMOR;
TUMOR XENOGRAFT;
ANIMALS;
ANTINEOPLASTIC AGENTS;
CLINICAL TRIALS, PHASE I AS TOPIC;
DRUG DESIGN;
DRUG EVALUATION, PRECLINICAL;
DRUGS, INVESTIGATIONAL;
HUMANS;
MICE;
NEOPLASMS;
|
|
EID: 77953207004
PISSN: 13697056
EISSN: None
Source Type: Journal
DOI: None Document Type: Conference Paper |
|
Times cited : (3)
|
|
References (0)
|
